Business StandardANAVEX® Life Sciences Corp.Jul 30, 20151 min readNew drug may boost brain power in Alzheimer’s patientsClick here to read article
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease
